tyb
10X Geonomics, Inc. sold by Foresite capital Mgmt I: $44.25m-Mar17
10x Genomics, Inc. is a life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium platform enables analysis of individual biological components, such as up to millions of single cells. Its Visium platform is designed to identify where biological components are located and how they are arranged with respect to each other. Its molecular assays are used with its Chromium platform, and with its planned Visium platform, to provide sensitive and robust biochemistries that convert minute amounts of biological analytes into detectable signals. Number of employees : 584 people.
>https://www.marketscreener.com/10X-GENOMICS-INC-65338646/company/
Foresite Capital is an American venture capital and growth equity firm. The company has offices in San Francisco and New York. As of May 2019, the company had raised four funds, Foresite Capital Fund I, II, III and IV. Foresite Capital was founded in 2011 by Jim Tananbaum, co-founder of Theravance, who became CEO of the company. Foresite Capital raised its $100 million Fund I in 2013. Foresite Capital has invested in companies such as Epizyme, Intarcia Therapeutics, Aerie Pharmaceuticals, Inscripta and Universal American. Foresite Capital funded 10x Genomics since its Series A round in November 2013 and led its Series B round in January 2015, as well as its Series C round in March 2016. In April 2014, Foresite Capital closed Foresite Capital Fund II, a $300 million fund. Foresite Capital Fund III, a $450 million fund, was closed in July 2015. Foresite Capital Fund IV, a $668 million fund, closed in March 2018. Its investments include DNAnexus, Editas Medicine Immunomedics, Intarcia Therapeutics, Intellia Therapeutics, Juno Therapeutics, Turning Point Therapeutics, Natera, Orexigen, Pacific Biosciences, MindStrong, Relay Therapeutics, Insitro, HealthVerity, Element Biosciences,and Portola Pharmaceuticals.
Foresite Capital is led by Midas List honoree Jim Tananbaum along with managing directors Matt Buten, Dorothy Margolskee, Brett Zbar, Dennis Ryan, and Vikram Bajaj.
>https://en.wikipedia.org/wiki/Foresite_Capital
https://www.finviz.com/insidertrading.ashx?oc=1581219&tc=7
Slack Technolgies, Inc. sold by Andreessen Horowitz: $17.46m-Mar 19
Slack Technologies, Inc. is engaged in offering Slack, a team communication tool. The Company's Slack allows users to organize their team conversations in open channels; make a channel for a project, a topic or a team, and create private channels and invite team members. Slack indexes and archives messages, notifications and files. Slack allows developers to create applications for an interface with bot users, slash commands and notifications. Its application program interfaces (APIs) can be used alone or in conjunction with each other to build various kinds of Slack applications. The Events API uses Slack's object-driven OAuth scope system to control access to events. Number of employees : 2 045 people.
Andreessen Horowitz aka a16z
Between 2006 and 2010, Andreessen and Horowitz actively invested in technology companies. Separately, and together, they invested $80 million in 45 start-ups including Twitter. During this time, the two became known as super angel investors. On July 6, 2009, Andreessen and Horowitz launched their venture capital fund with an initial capitalization of $300 million. In November 2010, at a time when the field of venture capitalism was contracting, the company raised another $650 million for a second venture fund. In less than two years, the firm was managing a total of $1.2 billion under the two funds. In May 2011, Andreessen ranked number 10 on the 2011 Forbes Midas List of Tech's Top Investors while he and Horowitz ranked number 6 on Vanity Fair’s 2011 New Establishment List and number 1 on CNET’s 2011 most influential investors list. As of March 27, 2014, the firm managed $4 billion in assets after the closing of its fourth fund at $1.5 billion. In addition to Andreessen and Horowitz, the firm’s general partners include John O’Farrell, Scott Weiss, Jeff Jordan, Peter Levine, Chris Dixon, Vijay Pande, Katie Haun, Alex Rampell, Martin Casado and Andrew Chen. In March 2019, it was reported that Andreessen Horowitz was opening an office in San Francisco.
>https://en.wikipedia.org/wiki/Andreessen_Horowitz
Marc Lowell Andreessen He is the co-author of Mosaic, the first widely used web browser; co-founder of Netscape; and co-founder and general partner of Silicon Valley venture capital firm Andreessen Horowitz. He founded and later sold the software company Opsware to Hewlett-Packard. Andreessen is also a co-founder of Ning, a company that provides a platform for social networking websites. He sits on the board of directors of Facebook. Andreessen was one of six inductees in the World Wide Web Hall of Fame announced at the First International Conference on the World-Wide Web in 1994.
https://www.finviz.com/insidertrading.ashx?oc=1191712&tc=7&b=2
>i 'member downloading mosaic from the U of Illinois server back in '93
Fuck you hair boi.
it's $26 and change right now…..
your statement is not worded very well.
>Would it drop to say 30 a barrel?
today the price is $26.xx not a few weeks ago.
that was very enjoyable…the class today. missed a gud time
I can't, for the life of me, understand why he doesn't mix it up a bit-it would be so much moar effective. but rainman gonna nig…at least he is consistent.